Financial Summary (All financials)
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| Revenue growth | | | | -100.0% | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 |
| Gross margin | | | | | -100.0% | | |
| Selling, general and administrative | 2.8 | 2.7 | | 1.7 | | | |
| Research and development | 2.0 | 1.0 | 0.4 | 0.4 | | | |
| General and administrative | | | 2.2 | | 0.1 | 0.1 | 0.0 |
| EBIT | -7.2 | -1.8 | -2.6 | -14.7 | -0.1 | -0.3 | -0.2 |
| EBIT margin | | | | | -193.9% | | |
| Pre-tax income | -7.8 | -2.6 | 4.3 | -15.7 | 0.0 | -0.2 | -0.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 0.1% | | 0.0% | | |
| Net income | -7.8 | -2.6 | 4.3 | -2.7 | 0.0 | -0.2 | -1.1 |
| Net margin | | | | | -21.2% | | |
| |
| Diluted EPS | ($0.18) | ($0.12) | $0.15 | ($0.12) | $0.00 | | |
| Shares outstanding (diluted) | 39.7 | 30.6 | 28.7 | 22.4 | 20.4 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|